Therapeutics News

In this Healio video, Jacquie M. Bowen, OD, president-elect of the American Optometric Association, discusses the AOA’s recent consumer alert about over-the-counter color-changing eye drops.

AiViva Biopharma announced that it has completed enrollment and dosing of the last patient in a phase 1 clinical trial of AIV007 for wet age-related macular degeneration and diabetic macular edema.

LENZ Therapeutics has submitted a new drug application to the FDA for LNZ100, a preservative-free, once-daily aceclidine-based ophthalmic solution designed to treat presbyopia, the company announced in a press release.

OcuSoft announced the launch of Retaine Allergy, a prescription-strength olopatadine hydrochloride ophthalmic solution 0.2% for eye allergy itch relief.

Eighteen medications appeared to be associated with angle-closure glaucoma, including sulfonamides, serotonergic agents and antimuscarinic agents, according to a retrospective analysis published in Ophthalmology Glaucoma.

Multiuse eye drop bottles are often discarded at medical centers long before the FDA-regulated expiration date, leading to significant drug waste and increased costs, according to research published in Ophthalmology.

Overtreating acute conjunctivitis with topical antibiotics may contribute to antibiotic resistance with no improvement in outcomes, according to a research letter published in JAMA Ophthalmology.

Lipid-based eye drops may help treat evaporative dry eye disease, although additional research, particularly with placebo-controlled study designs, is needed, according to a review.

A dexamethasone 0.4 mg intracanalicular insert was linked to greater improvement in corneal and conjunctival staining vs. a sham collagen plug among patients with aqueous-deficient dry eye, although it may increase IOP, research showed.